Spinal fluid fats linked to later cognitive impairment
An observational study followed cognitively unimpaired older adults and found that specific spinal fluid fats improved predictions of later cognitive impairment.

Limit: Sample collection timing was not standardized, which may have influenced measured lipid profiles
Stake: Authors hold shares in Johnson & Johnson. An author founded C2N Diagnostics.
Edited by Boris Djordjevic · AgingResearch.News
An observational study of cognitively unimpaired older adults measured lipids, or fat-like molecules, in blood plasma and cerebrospinal fluid, which surrounds the brain and spinal cord. Researchers followed participants for changes in a clinical rating of cognitive impairment.
Specific cerebrospinal fluid lipids independently predicted a later shift toward impairment on that rating and improved risk prediction. Overall, cerebrospinal fluid lipid patterns were primarily associated with age and established markers of Alzheimer’s disease. Some were also positively associated with markers of brain injury and inflammation. Blood plasma lipid patterns differed strongly by sex, while certain plasma lipids had modest links to cognitive decline risk.
Why it matters
Age-related cognitive decline raises the question of whether risk can be detected before symptoms begin. The authors highlighted how the brain processes lipids as a promising source of predictive markers and treatment targets.
Caveats
This observational study cannot establish that the lipids caused cognitive decline or that changing them would help. The abstract does not report participant numbers, follow-up length or how much the lipid measures improved risk prediction.
From the paper
- Participants
A total of 282 study subjects of cognitively unimpaired individuals from the MCSA were included in this study.
Results, 3.1 Associations between CSF and plasma lipids in cognitively unimpaired participants
Quoted word for word from the full text on alz-journals.onlinelibrary.wiley.com.
- Lipid and ceramide metabolism
- Cognitive impairment
- Mild cognitive impairment
- Plasma lipids
- Cognitive decline
- Humans
The paper
Mayo Clinic; The University of Texas at San Antonio Health Science Center
Alzheimer's & Dementia, Oct 2026, Open access


